Hosted on MSN15h
Airbus’ A320 ATRA with Eurofighter nose completes first flightThis aircraft, which now features the nose of a Eurofighter jet, has been transformed into a flying 'test bed' to test the new E-Scan radar. Airbus E-Scan radar project manager Th ...
Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at HC ...
The Aviationist on MSN1d
Airbus A320 ATRA Performs Maiden Flight After E-Scan AESA Radar ModificationThe Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...
Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...
This modified Airbus A320 testbed features a distinctive new element: the nose of a Eurofighter Typhoon jet. This ...
NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara ...
Short ATRA slightly under 8.11, target 4.38, stop loss @ 8.13 Check the time stamp on this data. Updated AI-Generated Signals ...
Atara Biotherapeutics, Inc.’s ATRA share price has dipped by 40.50%, which has investors questioning if this is right time to ...
Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
Shares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after the FDA issued a complete response letter (CRL) against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback